On this page
Tivdak
tisotumab vedotin-tftv
351(a) Standalone BLA
Overview
Source: Purple BookProprietary name
Tivdak
Proper name
tisotumab vedotin-tftv
Licence type
351(a)
BLA number
761208
Applicant
Seagen Inc.
Center
CDER
Presentations
1
First licensure
—
Presentations
Source: Purple Book| Strength | Dosage form | Route | Presentation | Status | Licensed |
|---|---|---|---|---|---|
| 40MG | For Injection | Intravenous | Single-Dose Vial | Rx | September 20, 2021 |
Sources for this page
| Purple Book | FDA | Licence type, presentations, reference product, exclusivity |